leuprolide
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leuprolide (Eligard) | KIT, INTRAMUSCULAR | 7.5 mg/month | ||||||||||||||
Leuprolide (Eligard) | KIT, INTRAMUSCULAR | 22.5 mg/3 months | ||||||||||||||
Leuprolide (Eligard) | KIT, INTRAMUSCULAR | 30 mg/4 months | ||||||||||||||
Leuprolide (Eligard) | KIT, INTRAMUSCULAR | 45 mg/6 months | ||||||||||||||
Leuprolide | KIT, SUBCUTANEOUS | 5 mg/mL (14 mg/2.8 mL) | ||||||||||||||
Leuprolide (Lupron Depot) | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 3.75 mg/month | ||||||||||||||
Leuprolide (Lupron Depot) | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 11.25 mg/3 months | ||||||||||||||
Leuprolide (Lupron Depot) | POWDER FOR INJECTION, EXTENDED RELEASE, SUBCUTANEOUS | 22.5 mg/3 months | ||||||||||||||
Leuprolide (Lupron Depot) | POWDER FOR INJECTION, EXTENDED RELEASE, SUBCUTANEOUS | 45 mg/6 months | ||||||||||||||
Leuprolide (Fensolvi) | SUSPENSION, SUBCUTANEOUS | 45 mcg |
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of leuprolide acetate (Fensolvi) 45 mcg for injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions
Rex Therapeutic Interchange